PubMed
Acetyl hexapeptide-3 in a emulsion formulation for reduced wrinkle depth
Raikou V, Varvaresou A, Panderi I, et al. J Cosmet Dermatol. 2009
Acetyl Octapeptide-3
Topical cosmetic peptide used in anti-wrinkle formulations.
Last reviewed . First published . By the PeptIQ team.
Overall check-ins
Trackers & reports
Overview
Topical cosmetic peptide used in anti-wrinkle formulations.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 0% · Mixed 100% · Unfavorable overall 0%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0–25 mcg · Most common: 0–25 mcg
Reports cluster around 0–25 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Research
PubMed
Raikou V, Varvaresou A, Panderi I, et al. J Cosmet Dermatol. 2009
PubMed
Solá P, Mereu E, Bonjoch J, et al. Nature aging. 2023
PubMed
Shook BA, Wasko RR, Rivera-Gonzalez GC, et al. Science (New York, N.Y.). 2018
Tools
More ways to learn about SNAP-8 from observational PeptIQ data.
Compare with
Related peptides
Help
This page summarizes 6 anonymized self-reports from PeptIQ users who track SNAP-8, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. SNAP-8 is listed as OTC Cosmetic. Consult a licensed clinician for personal medical decisions.
This wiki summarizes observational community reports and linked citations for SNAP-8. It does not assert therapeutic benefits. See the sources list on this page and the educational profile for SNAP-8 for study-level context — not medical advice.
SNAP-8 is listed in PeptIQ as OTC Cosmetic. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
Safety data quality for SNAP-8 varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
This page links 3 sources for SNAP-8. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.